Additionally, specific-purpose antioxidants introduced as potential treatment coadjutants, SOD (EUK-134) and CAT (manganese porphyrins) mimics demonstrated efficacy in animal models of diabetic nephropathy and resistant HTN opening the door to future human trials (Wilcox and Aslam, 2021). The gene discussed is SOD1; the disease is hypertensive disorder.